--- title: "Groundbreaking Research on Alzheimer's Disease Reveals Genetic Mutations Affect Nerve Movement" url: https://noti.group/groundbreaking-research-on-alzheimer-s-disease-reveals-genetic/ language: en publisher: "Noti Group" section: "Health" published: 2026-11-10T01:47:34.000Z updated: 2026-11-10T08:38:53.245Z id: 903de274-6af9-4299-9cbb-83cf09e957bf source: "ScienceDaily Health https://www.sciencedaily.com/releases/2026/11/261108233103.htm" attribution: "Link to https://noti.group/groundbreaking-research-on-alzheimer-s-disease-reveals-genetic/ and name Noti Group when you quote or summarize this story." --- # Groundbreaking Research on Alzheimer's Disease Reveals Genetic Mutations Affect Nerve Movement Researchers at the University of Central Florida have made a groundbreaking discovery about Alzheimer's disease, shedding new light on its effects beyond memory loss. The study reveals that genetic mutations linked to Alzheimer's can cause problems in the nerves controlling muscle movement, even before the brain or spinal cord is affected. This finding could explain why people with Alzheimer's often experience difficulties with walking, balance, and coordination long before noticeable cognitive decline sets in. The scientists behind the research believe that these physical symptoms may serve as earlier warning signs of the disease, potentially allowing for intervention to delay its onset. The study was led by James Hickman and Xiufang "Nadine Guo, who worked alongside colleagues at Hesperos, a healthcare technology company. Funded by the National Institutes of Health's National Institute on Aging, the research utilized laboratory systems built from human cells to investigate how inherited Alzheimer's mutations impact movement. The study's findings were published in a leading scientific journal and suggest that treatments focused solely on the brain may overlook important issues elsewhere in the body. Guo notes that motor deficits could be an early indication of Alzheimer's, potentially providing a window for earlier intervention and treatment. Alzheimer's is commonly associated with memory loss, confusion, and cognitive decline, but doctors have observed that some patients develop physical symptoms years before clear cognitive difficulties become apparent. These symptoms include changes in balance, coordination, and gait. The research highlights the need to consider the broader effects of Alzheimer's on the body, rather than just focusing on its impact on memory and cognition. By exploring this new avenue of inquiry, scientists may be able to develop more effective treatments for the disease. Researchers are re-examining the relationship between Alzheimer's disease and movement problems, questioning whether damage in the brain is solely responsible for these issues or if the disease itself interferes directly with nerves outside of the brain. To explore this new avenue of inquiry, a team at the University of Central Florida focused on familial Alzheimer's, a rare inherited form of the disease that typically affects individuals between 40 and 65 years old. This approach allowed them to study the effects of the disease in a more controlled environment. Their experiments revealed that motor neurons carrying mutations linked to familial Alzheimer's can disrupt muscle control even when the brain and spinal cord are absent from the system. This suggests that Alzheimer's mutations may directly interfere with nerve function, rather than solely affecting movement through damage to the brain. The study highlights the importance of considering the peripheral nervous system in understanding Alzheimer's disease. The peripheral nervous system includes nerves outside of the brain and spinal cord, which transmit signals between the central nervous system and the rest of the body, controlling movement, sensation, and other essential functions. Protecting motor function could have benefits beyond physical health, as regular physical activity is associated with better cognitive well-being. Preserving the ability to move may also support brain health, suggesting that treating Alzheimer's disease should not be limited to targeting the brain alone. Scientists have been exploring new ways to understand Alzheimer's disease, a condition that affects millions worldwide. To gain insights into its mechanisms, researchers turned to an innovative laboratory platform known as human-on-a-chip technology. Developed by Hesperos, a company co-founded by Hickman, this miniature system brings together different types of human cells under controlled conditions. It allows scientists to recreate specific biological functions and observe how diseases like Alzheimer's interfere with them. This approach differs significantly from traditional laboratory experiments that examine isolated cells in isolation. The human-on-a-chip" technology can reproduce crucial interactions between various tissues, providing a more accurate representation of how human diseases behave. For the study, researchers created a miniature model of the neuromuscular junction, where motor neurons communicate with muscle cells. They deliberately designed this model without a brain or spinal cord to investigate whether Alzheimer's-related changes could cause movement problems independently of the central nervous system. The team combined healthy muscle cells with motor neurons derived from stem cells carrying genetic mutations associated with familial Alzheimer's disease. These stem cells have the ability to develop into specialized types of cells, making them valuable tools for studying human diseases in the laboratory. By examining how effectively altered nerve cells communicated with otherwise healthy muscle tissue, researchers found that Alzheimer's-associated mutations could interfere with normal nerve-to-muscle function. This suggests that some movement difficulties linked to the disease may arise directly in the peripheral nervous system rather than being caused entirely by brain degeneration. Every voluntary movement requires seamless communication between the nervous system and muscles for it to happen smoothly. This process begins at the neuromuscular junction, where an electrical signal from a motor neuron triggers chemical signals that cause muscle contractions. This intricate dance of electrical and chemical impulses enables us to perform everyday activities such as walking, maintaining posture, lifting objects, and making precise movements. When the connection between nerve and muscle becomes impaired, muscles may respond less effectively to nerve signals. As a result, individuals may experience weakness, reduced coordination, or difficulty sustaining physical activity depending on the severity and location of the problem. To assess these effects, researchers measured how consistently nerve signals produced muscle contractions and how long muscles could continue contracting before becoming fatigued. These measurements provided a direct evaluation of how well nerve and muscle cells worked together, mirroring aspects of functional testing used by physicians in patients with movement disorders. The study's findings suggest that impaired nerve-to-muscle communication can occur even in systems without brain or spinal cord involvement, offering evidence that mutations linked to familial Alzheimer's can produce effects beyond the central nervous system. Further research will be necessary to determine how closely laboratory findings reflect the progression of Alzheimer's disease in people, particularly those with more common forms of the condition. The research on Alzheimer's disease is taking an interesting turn as scientists explore new avenues for detection and treatment. A recent study has uncovered potential warning signs of Alzheimer's outside the brain, specifically in motor function. This finding suggests that researchers may need to look beyond traditional indicators such as memory loss when investigating the disease. If confirmed by future studies, changes in walking, coordination, or nerve-to-muscle activity could become early indicators of Alzheimer's-related changes before more obvious neurological symptoms appear. This shift in focus raises questions about the effectiveness of current treatments that target the central nervous system. Researchers wonder whether medications designed to address brain processes may not necessarily correct abnormalities affecting peripheral nerves and muscles. The implications of this discovery are significant, as it could lead to a better understanding of how Alzheimer's affects physical function alongside cognitive health. The discovery marks the end of three decades of work by researchers who aimed to create more realistic laboratory models for studying diseases. These advanced systems allow scientists to study disease progression in a way that closely mimics what happens in the human body, making it easier to develop effective treatments. This breakthrough has significant implications for understanding how Alzheimer's affects not just cognitive health but also physical function. --- Source: [ScienceDaily Health](https://www.sciencedaily.com/releases/2026/11/261108233103.htm) Published by Noti Group: https://noti.group/groundbreaking-research-on-alzheimer-s-disease-reveals-genetic/